专题:Pathogenesis and Treatment of Hiccups

This cluster of papers explores the pathogenesis, pharmacological treatment, and management of hiccups, with a focus on neurological disorders, palliative care, and the use of medications such as gabapentin and corticosteroids. It also discusses the association between hiccups and cardiac arrhythmias, as well as the potential use of vagus nerve stimulation. The research covers various aspects of hiccups, including their neurological basis and potential treatments in different medical contexts.
最新文献
Drug-associated Takotsubo syndrome risk profiling: a global pharmacovigilance study

article Full Text OpenAlex

Psychiatric disorders in Takotsubo syndrome: clinical profiles and outcomes

article Full Text OpenAlex

SGLT2 inhibitors are associated with improved long-term survival in Takotsubo syndrome: insights from large-scale real-world data

article Full Text OpenAlex

Treatment and outcomes in patients with non-TB mycobacterial pulmonary disease: a single-centre study

article Full Text OpenAlex

Postural Orthostatic Tachycardia Syndrome: A State-of-the-Art Review

article Full Text OpenAlex

The Pathogenesis, Clinical Features, and Treatment of Corynebacterium striatum-Related Infection

article Full Text OpenAlex

Examining the Unanswered Questions in TSW: A Case Series of 16 Patients and Review of the Literature

article Full Text OpenAlex

BRASH syndrome in critical care settings: do we know enough?

article Full Text OpenAlex

Drug-induced liver injury from high-dose intravenous methylprednisolone: A rare but known adverse effect

article Full Text OpenAlex

Associations Between Hiccups and Subsequent Cancer Diagnoses: A Population‐Based Cohort Study

article Full Text OpenAlex

近5年高被引文献
Takotsubo Syndrome: Pathophysiology, Emerging Concepts, and Clinical Implications

article Full Text OpenAlex 331 FWCI49.0956

Effects of Non-steroidal Anti-inflammatory Drugs (NSAIDs) and Gastroprotective NSAIDs on the Gastrointestinal Tract: A Narrative Review

review Full Text OpenAlex 200 FWCI49.2538

AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome With Diarrhea

article Full Text OpenAlex 146 FWCI21.814

2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting

article Full Text OpenAlex 119 FWCI69.3571

Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial

article Full Text OpenAlex 115 FWCI32.3174

Evidence-based clinical practice guidelines for functional dyspepsia 2021

review Full Text OpenAlex 114 FWCI23.9786

DRG afferents that mediate physiologic and pathologic mechanosensation from the distal colon

article Full Text OpenAlex 84 FWCI23.6574

Diagnosis and Treatment of Irritable Bowel Syndrome: Clinical Recommendations of the Russian Gastroenterological Association and Association of Coloproctologists of Russia

article Full Text OpenAlex 61 FWCI9.745

Worldwide prevalence and burden of gastroparesis‐like symptoms as defined by the United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis

article Full Text OpenAlex 54 FWCI8.7618

Quality of life in irritable bowel syndrome: Exploring mediating factors through structural equation modelling

article Full Text OpenAlex 52 FWCI7.1061